Literature DB >> 16728505

Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

Hal P Bogerd1, Heather L Wiegand, Amy E Hulme, José L Garcia-Perez, K Sue O'Shea, John V Moran, Bryan R Cullen.   

Abstract

Long interspersed element (LINE) 1 retrotransposons are major genomic parasites that represent approximately 17% of the human genome. The LINE-1 ORF2 protein is also responsible for the mobility of Alu elements, which constitute a further approximately 11% of genomic DNA. Representative members of each element class remain mobile, and deleterious retrotransposition events can induce spontaneous genetic diseases. Here, we demonstrate that APOBEC3A and APOBEC3B, two members of the APOBEC3 family of human innate antiretroviral resistance factors, can enter the nucleus, where LINE-1 and Alu reverse transcription occurs, and specifically inhibit both LINE-1 and Alu retrotransposition. These data suggest that the APOBEC3 protein family may have evolved, at least in part, to defend the integrity of the human genome against endogenous retrotransposons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728505      PMCID: PMC1482655          DOI: 10.1073/pnas.0603313103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Transport between the cell nucleus and the cytoplasm.

Authors:  D Görlich; U Kutay
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

2.  The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.

Authors:  Guylaine Haché; Mark T Liddament; Reuben S Harris
Journal:  J Biol Chem       Date:  2005-01-12       Impact factor: 5.157

Review 3.  Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors.

Authors:  Bryan R Cullen
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Unconventional translation of mammalian LINE-1 retrotransposons.

Authors:  Reid S Alisch; Jose L Garcia-Perez; Alysson R Muotri; Fred H Gage; John V Moran
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

5.  Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.

Authors:  Brian P Doehle; Alexandra Schäfer; Bryan R Cullen
Journal:  Virology       Date:  2005-09-01       Impact factor: 3.616

6.  Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.

Authors:  Brian P Doehle; Alexandra Schäfer; Heather L Wiegand; Hal P Bogerd; Bryan R Cullen
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Identification of an NTF2-related factor that binds Ran-GTP and regulates nuclear protein export.

Authors:  B E Black; L Lévesque; J M Holaska; T C Wood; B M Paschal
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

8.  Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.

Authors:  James A Dutko; Alexandra Schäfer; Alison E Kenny; Bryan R Cullen; M Joan Curcio
Journal:  Curr Biol       Date:  2005-04-12       Impact factor: 10.834

9.  APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.

Authors:  Hui Chen; Caroline E Lilley; Qin Yu; Darwin V Lee; Jody Chou; Iñigo Narvaiza; Nathaniel R Landau; Matthew D Weitzman
Journal:  Curr Biol       Date:  2006-03-07       Impact factor: 10.834

10.  APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells.

Authors:  Hal P Bogerd; Heather L Wiegand; Brian P Doehle; Kira K Lueders; Bryan R Cullen
Journal:  Nucleic Acids Res       Date:  2006-01-10       Impact factor: 16.971

View more
  233 in total

1.  Retrotransposition of marked SVA elements by human L1s in cultured cells.

Authors:  Dustin C Hancks; John L Goodier; Prabhat K Mandal; Ling E Cheung; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2011-06-02       Impact factor: 6.150

2.  APOBEC3 proteins and genomic stability: the high cost of a good defense.

Authors:  Iñigo Narvaiza; Sébastien Landry; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

3.  Epigenetic control of retrotransposon expression in human embryonic stem cells.

Authors:  Angela Macia; Martin Muñoz-Lopez; Jose Luis Cortes; Robert K Hastings; Santiago Morell; Gema Lucena-Aguilar; Juan Antonio Marchal; Richard M Badge; Jose Luis Garcia-Perez
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

4.  LINE-1 activity as molecular basis for genomic instability associated with light exposure at night.

Authors:  Victoria P Belancio
Journal:  Mob Genet Elements       Date:  2015-04-07

5.  Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Authors:  Judd F Hultquist; Reuben S Harris
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

6.  Cell divisions are required for L1 retrotransposition.

Authors:  Xi Shi; Andrei Seluanov; Vera Gorbunova
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

Review 7.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

Review 8.  Unveiling Human Non-Random Genome Editing Mechanisms Activated in Response to Chronic Environmental Changes: I. Where Might These Mechanisms Come from and What Might They Have Led To?

Authors:  Loris Zamai
Journal:  Cells       Date:  2020-10-27       Impact factor: 6.600

9.  Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Authors:  Hal P Bogerd; Rebecca L Tallmadge; J Lindsay Oaks; Susan Carpenter; Bryan R Cullen
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

10.  Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.

Authors:  Andrew E Armitage; Aris Katzourakis; Tulio de Oliveira; John J Welch; Robert Belshaw; Kate N Bishop; Beatrice Kramer; Andrew J McMichael; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.